Concourse Financial Group Securities’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,281
| Closed | -$145K | – | 7467 |
|
|
2024
Q4 | $145K | Sell |
11,281
-1,199
| -10% | -$15.5K | 0.01% | 830 |
|
|
2024
Q3 | $177K | Sell |
12,480
-919
| -7% | -$13.1K | 0.01% | 751 |
|
|
2024
Q2 | $173K | Buy |
13,399
+12,795
| +2,118% | +$166K | 0.01% | 731 |
|
|
2024
Q1 | $8.39K | Buy |
604
+370
| +158% | +$5.14K | ﹤0.01% | 1758 |
|
|
2023
Q4 | $3.34K | Sell |
234
-37
| -14% | -$528 | ﹤0.01% | 1935 |
|
|
2023
Q3 | $4.19K | Hold |
271
| – | – | ﹤0.01% | 1860 |
|
|
2023
Q2 | $4.26K | Sell |
271
-9
| -3% | -$141 | ﹤0.01% | 1870 |
|
|
2023
Q1 | $4.61K | Hold |
280
| – | – | ﹤0.01% | 1889 |
|
|
2022
Q4 | $4.37K | Sell |
280
-1
| -0.4% | -$16 | ﹤0.01% | 1887 |
|
|
2022
Q3 | $4K | Buy |
+281
| New | +$4K | ﹤0.01% | 1696 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6917 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6781 |
|
|
2021
Q4 | – | Sell |
-1,000
| Closed | -$16K | – | 6694 |
|
|
2021
Q3 | $16K | Hold |
1,000
| – | – | ﹤0.01% | 1729 |
|
|
2021
Q2 | $17K | Hold |
1,000
| – | – | ﹤0.01% | 1693 |
|
|
2021
Q1 | $18K | Hold |
1,000
| – | – | ﹤0.01% | 1594 |
|
|
2020
Q4 | $18K | Buy |
+1,000
| New | +$18K | ﹤0.01% | 1494 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5635 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5494 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5443 |
|
|
2019
Q4 | – | Sell |
-87
| Closed | -$1K | – | 5361 |
|
|
2019
Q3 | $1K | Buy |
+87
| New | +$1K | ﹤0.01% | 1691 |
|
|
2019
Q2 | – | Sell |
-1,061
| Closed | -$21K | – | 5272 |
|
|
2019
Q1 | $21K | Buy |
+1,061
| New | +$21K | ﹤0.01% | 1252 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5085 |
|